Douglas A Roeder has an estimated net worth of $131 Million. This is based on reported shares across multiple companies, which include ALDER BIOPHARMACEUTICALS INC, TriVascular Technologies, Inc., TANDEM DIABETES CARE INC, Senseonics Holdings, Inc., Calithera Biosciences, Inc., and TRANS1 INC.

2014 was Douglas A Roeder's most active year for acquiring shares with 31 total transactions. Douglas A Roeder's most active month to acquire stocks was the month of April. 2014 was Douglas A Roeder's most active year for disposing of shares, totalling 16 transactions. Douglas A Roeder's most active month to dispose stocks was the month of March. 2014 saw Douglas A Roeder paying a total of $28,499,992.00 for 14,370,944 shares, this is the most they've acquired in one year. In 2019 Douglas A Roeder cashed out on 366,803 shares for a total of $25,779,474.89, their largest year based on trade value.